AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21761190
Drug: Standard cromoglycate
RxNorm normalized name: cromoglycate
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard cromoglycate combination therapy (CGC)
Trial: 16002030
Drug: 21 mg
RxNorm normalized name: aspirin 421 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg transdermal nicotine patch
Trial: 23868855
Drug: Trivair Nasal
RxNorm normalized name: triamcinolone acetonide Prefilled Syringe [Trivaris]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivair Nasal Deposition System delivering anhydrous lactose particles (5 μm and 50 μm at doses of 12.5 mg and 25 mg)
Trial: 10219066
Drug: D-chiro-inositol (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-chiro-inositol (1200 mg once daily for 6-8 weeks)
Trial: 9661119
Drug: 0.03 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 mg/kg rhGH
Trial: 9661119
Drug: 0.06 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.06 mg/kg rhGH
Trial: 7191647
Drug: Bupivacaine 0.75%
RxNorm normalized name: BUPivacaine 0.75% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.75% in 8.25% dextrose, 12 mg
Trial: 7191647
Drug: Tetracaine, 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracaine, 12 mg
Trial: 7191647
Drug: Epinephrine added
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine added to local anesthetic solution
Trial: 30359438
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g sucrose (control)
Trial: 22856247
Drug: Control biscuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control biscuits (100 g providing 497 kcal and 11.36 g of protein)
Trial: 16008116
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg EGCG
Trial: 12655619
Drug: Individual cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive-behavioral therapy (CBT)
Trial: 12655619
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral therapy (CBT)
Trial: 11034937
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg testosterone daily by transdermal patch
Trial: 2054265
Drug: Magnesium hydroxide
RxNorm normalized name: Magnesium Hydroxide
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium hydroxide (850 mg)
Trial: 27077673
Drug: PEGylated‐interferonα2b (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEGylated‐interferonα2b (1.5 μg/kg/week) + ribavirin (800‐1400 mg/day) + boceprevir (800 mg TID)
Trial: 22909899
Drug: Oseltamivir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir monotherapy (O)
Trial: 18076252
Drug: Sports Gel
RxNorm normalized name: Snow & sun sports gel
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports Gel
Trial: 18303227
Drug: Deep sclerectomy
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep sclerectomy with low-dosage mitomycin C (DSMMC)
Trial: 18303227
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with low-dosage mitomycin C (TPMMC)
Trial: 7547820
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg temazepam elixir
Trial: 8248349
Drug: RU 486
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 486 (10 mg/kg)
Trial: 23527884
Drug: Open-label therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label therapy after optimization
Trial: 12756640
Drug: Systemic cephalexin
RxNorm normalized name: Cephalexin
DrugBank: Cephalexin (DB00567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic cephalexin and ethyl lactate shampoo therapy
Trial: 9510449
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment for phenylketonuria (PKU)
Trial: 29136336
Drug: Sertraline 100
RxNorm normalized name: sertraline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 100 mg single oral dose
Trial: 26871201
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg starch (placebo)
Trial: 22964926
Drug: Budesonide-formoterol combination
RxNorm normalized name: budesonide / formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide-formoterol combination (400 µg budesonide and 12 µg formoterol)
Trial: 22964926
Drug: Budesonide alone
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide alone (400 µg)
Trial: 8810809
Drug: 13C-urea (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13C-urea (50 mg)
Trial: 8810809
Drug: 13C-urea (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13C-urea (100 mg)
Trial: 1191783
Drug: Scheme I:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheme I: 100 rad 3 times a day, 5 days a week, total tumor dose of 8,400 rad, with 2 weeks of rest in the middle of treatment.
Trial: 1191783
Drug: Scheme II:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheme II: 200 rad once a day, 5 days a week, total tumor dose of 6,400 rad, with 2 weeks of rest in the middle of treatment.
Trial: 12933402
Drug: Ephedrine 0.1
RxNorm normalized name: Primatene with ephedrine 0.125 MG/ACTUAT Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 0.1 mg/kg
Trial: 322547
Drug: Ketamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2 mg/ml) administered by microdrip at an average rate of 10 ml/min
Trial: 322547
Drug: Innovar (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Innovar (0.1 ml/ml) administered by microdrip at an average rate of 10 ml/min
Trial: 17192165
Drug: Allopurinol (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (standard therapy)
Trial: 16380617
Drug: Atomoxetine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (0.5 to 1.5 mg/kg/day)
Trial: 8604540
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (local hypotensive therapy only)
Trial: 913121
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg flurbiprofen daily
Trial: 334476
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg phenylbutazone daily
Trial: 23545863
Drug: Levosimendan 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan 0.1 μg/kg/min
Trial: 3552679
Drug: Digoxin with
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin with verapamil (120 mg daily)
Trial: 3552679
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose digoxin
Trial: 31732098
Drug: Nivolumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab plus Ipilimumab (nivolumab 3 mg/kg plus ipilimumab 1 mg/kg every 3 wk for four doses, then nivolumab 3 mg/kg every 2 wk)
Trial: 31732098
Drug: Sunitinib (50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (50 mg once daily, 4 wk on, 2 wk off)
Trial: 27053382
Drug: extruded FePP‐fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: extruded FePP‐fortified rice with CA/TSC solution added after cooking (CA/TSC solution)
Trial: 27053382
Drug: nonextruded rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nonextruded rice fortified with a FeSO4 solution added after cooking (reference)
Trial: 10443077
Drug: Bilateral ECT
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ECT and flupenthixol (12‐24 mg/d)
Trial: 7589058
Drug: Propranolol with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol with ascorbic acid (2 g)
Trial: 2148876
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with cyclophosphamide/methotrexate/5-fluorouracil (CMF)
Trial: 24756009
Drug: Prednisone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (40 mg/day)
Trial: 22823594
Drug: Indomethacin 75
RxNorm normalized name: indomethacin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 75 mg slow release taken orally twice daily for 2.5 days
Trial: 22823594
Drug: Placebo taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo taken orally twice daily for 2.5 days
Trial: 10596204
Drug: Cisatracurium priming
RxNorm normalized name: Cisatracurium
DrugBank: Cisatracurium (DB00565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisatracurium priming (0.01 mg/kg)
Trial: 10596204
Drug: Pancuronium priming
RxNorm normalized name: pancuronium
DrugBank: Pancuronium (DB01337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pancuronium priming (0.015 mg/kg)
Trial: 1882007
Drug: Buspirone, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone, 15 mg per day
Trial: 28981503
Drug: Topical formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical formulation of leaf of Juniperus excelsa extract
Trial: 27017763
Drug: Group F
RxNorm normalized name: Prostaglandin group F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group F (low-dose and addition of fentanyl): received intrathecally 0.5% hyperbaric bupivacaine (70% of group B) with fentanyl 20 mg and epidural catheter at T12‐L1.
Trial: 27017763
Drug: Group E
RxNorm normalized name: Prostaglandin group E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group E (low-dose and epidural volume extension): received intrathecally 0.5% hyperbaric bupivacaine (70% of group B) and epidural catheter at L3‐4, with 10 ml saline injected 3 minutes after intrathecal injection.
Trial: 27017763
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (conventional dose): received intrathecally 0.5% hyperbaric bupivacaine (10 mg; < 160 cm in height 11 mg; > 160 cm in height) and epidural catheter at T12‐L1.
Trial: 24463478
Drug: Dexmedetomidine bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine bolus (0.5μg/kg) after delivery and sufentanil with dexmedetomidine PCA (background infusion of 0.045μg/kg/h with a bolus of 0.07μg/kg)
Trial: 21870106
Drug: Berberine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berberine (300 mg, t.i.d., p.o.)
Trial: 19608826
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution without alanyl-glutamine
Trial: 18215726
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/d for 6 weeks, then increased to 10 mg/d for 20 weeks)
Trial: 30888593
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (2 g/day) with a normal diet (2000 kcal/day) during 4 weeks
Trial: 23953895
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (ESWT) - 4000 pulses at 0.25 mJ/mm² weekly for 4 weeks
Trial: 19369294
Drug: Mifepristone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 25 mg given twice on day 1 followed by 4 days of EE 20 microg
Trial: 19369294
Drug: Mifepristone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 25 mg given twice on day 1 plus doxycycline 100 mg twice daily for 5 days
Trial: 29462266
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice daily for 5 days
Trial: 19369294
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice daily with EE 20 microg daily
Trial: 16284061
Drug: Placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo twice daily for 5 days
Trial: 12548256
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera gel gloves used 8 hours/day for 30 days
Trial: 12548256
Drug: No use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No use of aloe vera gel gloves (control)
Trial: 8695134
Drug: Desflurane anesthesia
RxNorm normalized name: Desflurane
DrugBank: Desflurane (DB01189)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desflurane anesthesia with mivacurium infusion
Trial: 8695134
Drug: Isoflurane anesthesia
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane anesthesia with mivacurium infusion
Trial: 28318850
Drug: Hyperosmolar irrigation
RxNorm normalized name: HYPEROSMOTIC LAXATIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperosmolar irrigation solution (593 mOsm/L)
Trial: 22389080
Drug: Social drinkers
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social drinkers exposed to drug cue imagery
Trial: 12453549
Drug: Trial of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trial of diuretics for diagnosis.
Trial: 12453549
Drug: Awareness of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Awareness of the impact of angiotensin‐converting enzyme inhibitors.
Trial: 9165135
Drug: 66 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 66 Gy in 33 2 Gy daily fractions in 45-48 days (o.d.)
Trial: 3119481
Drug: Standard solution
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard solution containing crystalline amino acids (3.8 g/l), xylitol (25 g/l) and sorbitol (25 g/l), accounting for a total of 900 cal/day
Trial: 29316945
Drug: Academic detailing
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Academic detailing visit on appropriate prescribing of pain relief medication
Trial: 24746411
Drug: Pulverized brand-name
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulverized brand-name and generic drugs containing candesartan (Atacand(®), Cansartan‐Mepha(®), Pemzek(®))
Trial: 14706729
Drug: Alternative monotherapy
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative monotherapy
Trial: 10803803
Drug: L-acetylcarnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-acetylcarnitine
Trial: 8641911
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy consisting of prophylactic hepatic irradiation and pancreatic bed irradiation with concurrent infusional 5‐fluorouracil (200 mg/m2/day) and leucovorin (5 mg/m2/day) for 5 out of every 7 days during the 38‐day treatment sequence.
Trial: 17115349
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin aspart (BIAsp)
Trial: 31566438
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor (ACEi)
Trial: 8666715
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg diazepam
Trial: 8071269
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg zolpidem
Trial: 9443518
Drug: 0.65+0.35 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.65+0.35 g/kg ethanol
Trial: 26967896
Drug: Rocuronium (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.4 mg/kg)
Trial: 25012985
Drug: Telotristat etiprate
RxNorm normalized name: Telotristat etiprate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telotristat etiprate 500 mg tid
Trial: 7273791
Drug: Single agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agent sequential treatment
Trial: 24260764
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of erdosteine and nasal corticosteroid spray
Trial: 21288804
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of IXIARO (IC51) administered 15 months after primary immunization.
Trial: 19595518
Drug: Topiramate (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (up to 300 mg/day)
Trial: 16458598
Drug: 16-h nicotine
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16-h nicotine patch
Trial: 12549956
Drug: Desloratadine (once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine (once-daily treatment)
Trial: 10965735
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg oral dexketoprofen
Trial: 8527271
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral ketoprofen
Trial: 22237311
Drug: SB-649868 30
RxNorm normalized name: SB-649868
DrugBank: SB-649868 (DB14822)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-649868 30 mg
Trial: 8543491
Drug: Meropenem 500
RxNorm normalized name: meropenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500 mg intravenously every 8 h
Trial: 8543491
Drug: Ceftazidime 250-1000
RxNorm normalized name: ceftazidime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 250-1000 mg intravenously every 8 h
Trial: 8543491
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g every 8 h + amikacin 15 mg/kg/day
Trial: 8543491
Drug: Meropenem 1
RxNorm normalized name: meropenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 1 g every 8 h
Trial: 2394323
Drug: Low infusion
RxNorm normalized name: Solution, Multi Ingredient Topical application Solution [AVEENO POSITIVELY RADIANT MAXGLOW INFUSION DROPS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low infusion rates
Trial: 7436164
Drug: Activated oral
RxNorm normalized name: typhoid vaccine, inactivated oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated oral charcoal, 6 g daily for 8 weeks
Trial: 24924991
Drug: Augmented post-remission
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented post-remission therapy (regimen C) including additional eight doses of pegylated asparaginase, 18 doses of vincristine, and escalated-dose intravenous methotrexate without folinic acid rescue.
Trial: 24924991
Drug: Augmented post-remission
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented post-remission therapy (regimen C).
Trial: 24924991
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (treatment regimens A and B).
Trial: 19916990
Drug: Allopurinol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (300 mg once daily for 3 months)
Trial: 17515510
Drug: Topical 0.4%
RxNorm normalized name: fluoride topical 0.4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.4% retinol lotion
Trial: 15477633
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg once daily)
Trial: 12756078
Drug: Tamoxifen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20 mg once daily)
Trial: 11472700
Drug: RPR 109891
RxNorm normalized name: Nxl-103 component rpr-202868
DrugBank: Linopristin (DB19296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPR 109891 (oral glycoprotein IIb/IIIa antagonist) plus aspirin
Trial: 11472700
Drug: RPR 109891
RxNorm normalized name: Nxl-103 component rpr-202868
DrugBank: Linopristin (DB19296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPR 109891 (oral glycoprotein IIb/IIIa antagonist)
Trial: 9551029
Drug: fluvastatin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluvastatin 60 mg/day
Trial: 9551029
Drug: fenofibrate (micronized)
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: fenofibrate (micronized) 200 mg/day
Trial: 9551029
Drug: simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin 20 mg/day
Trial: 673095
Drug: Aluminum carbonate
RxNorm normalized name: ALUMINUM CARBONATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum carbonate powder in capsule form
Trial: 31383235
Drug: Montelukast and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast and fluticasone (anti-inflammatory treatment) for 12 weeks
Trial: 28498504
Drug: Varenicline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (2 mg/day, after 1-week dose run-up)
Trial: 28498504
Drug: NRT (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRT (21 mg/day decreasing to 7 mg/day)
Trial: 20652250
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard care with low molecular weight heparin)